242 related articles for article (PubMed ID: 34333033)
1. CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection Irrespective of HIV infection in low TB burden countries.
Chendi BH; Tveiten H; Snyders CI; Tonby K; Jenum S; Nielsen SD; Hove-Skovsgaard M; Walzl G; Chegou NN; Dyrhol-Riise AM
J Infect; 2021 Oct; 83(4):433-443. PubMed ID: 34333033
[TBL] [Abstract][Full Text] [Related]
2. Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection.
Petruccioli E; Chiacchio T; Navarra A; Vanini V; Cuzzi G; Cimaglia C; Codecasa LR; Pinnetti C; Riccardi N; Palmieri F; Antinori A; Goletti D
J Infect; 2020 May; 80(5):536-546. PubMed ID: 32097688
[TBL] [Abstract][Full Text] [Related]
3. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy.
Wergeland I; Pullar N; Assmus J; Ueland T; Tonby K; Feruglio S; Kvale D; Damås JK; Aukrust P; Mollnes TE; Dyrhol-Riise AM
J Infect; 2015 Apr; 70(4):381-91. PubMed ID: 25597826
[TBL] [Abstract][Full Text] [Related]
4. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
[TBL] [Abstract][Full Text] [Related]
5. Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study.
Kaforou M; Wright VJ; Oni T; French N; Anderson ST; Bangani N; Banwell CM; Brent AJ; Crampin AC; Dockrell HM; Eley B; Heyderman RS; Hibberd ML; Kern F; Langford PR; Ling L; Mendelson M; Ottenhoff TH; Zgambo F; Wilkinson RJ; Coin LJ; Levin M
PLoS Med; 2013 Oct; 10(10):e1001538. PubMed ID: 24167453
[TBL] [Abstract][Full Text] [Related]
6. Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting.
Clifford V; Tebruegge M; Zufferey C; Germano S; Forbes B; Cosentino L; Matchett E; McBryde E; Eisen D; Robins-Browne R; Street A; Denholm J; Curtis N
Tuberculosis (Edinb); 2019 Jan; 114():91-102. PubMed ID: 30711163
[TBL] [Abstract][Full Text] [Related]
7. Gaps in Study Design for Immune Parameter Research for Latent Tuberculosis Infection: A Systematic Review.
Herrera M; Vera C; Keynan Y; Rueda ZV
J Immunol Res; 2020; 2020():8074183. PubMed ID: 32377537
[TBL] [Abstract][Full Text] [Related]
8. Potential Immunological Biomarkers for Detection of Mycobacterium tuberculosis Infection in a Setting Where M. tuberculosis Is Endemic, Ethiopia.
Teklu T; Kwon K; Wondale B; HaileMariam M; Zewude A; Medhin G; Legesse M; Pieper R; Ameni G
Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311240
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
[TBL] [Abstract][Full Text] [Related]
10. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection.
Luo J; Zhang M; Yan B; Li F; Guan S; Chang K; Jiang W; Xu H; Yuan T; Chen M; Deng S
J Infect; 2019 Apr; 78(4):281-291. PubMed ID: 30528869
[TBL] [Abstract][Full Text] [Related]
12. Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis.
Delemarre EM; van Hoorn L; Bossink AWJ; Drylewicz J; Joosten SA; Ottenhoff THM; Akkerman OW; Goletti D; Petruccioli E; Navarra A; van den Broek BTA; Paardekooper SPA; van Haeften I; Koenderman L; Lammers JJ; Thijsen SFT; Hofland RW; Nierkens S
Front Immunol; 2021; 12():725447. PubMed ID: 34691031
[TBL] [Abstract][Full Text] [Related]
13. Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection.
Delogu G; Vanini V; Cuzzi G; Chiacchio T; De Maio F; Battah B; Pinnetti C; Sampaolesi A; Antinori A; Goletti D
Scand J Immunol; 2016 Dec; 84(6):344-352. PubMed ID: 27636597
[TBL] [Abstract][Full Text] [Related]
14. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
[TBL] [Abstract][Full Text] [Related]
15. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
[TBL] [Abstract][Full Text] [Related]
16. Heme oxygenase-1 and neopterin plasma/serum levels and their role in diagnosing active and latent TB among HIV/TB co-infected patients: a cross sectional study.
Uwimaana E; Bagaya BS; Castelnuovo B; Kateete DP; Godwin A; Kiwanuka N; Whalen CC; Joloba ML
BMC Infect Dis; 2021 Jul; 21(1):711. PubMed ID: 34315412
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium tuberculosis thymidylate kinase antigen assays for designating incipient, high-risk latent M.tb infection.
Wayengera M; Kateete DP; Asiimwe B; Joloba ML
BMC Infect Dis; 2018 Mar; 18(1):133. PubMed ID: 29548281
[TBL] [Abstract][Full Text] [Related]
18. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
La Manna MP; Orlando V; Li Donni P; Sireci G; Di Carlo P; Cascio A; Dieli F; Caccamo N
PLoS One; 2018; 13(3):e0192664. PubMed ID: 29543810
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV.
Kusejko K; Günthard HF; Olson GS; Zens K; Darling K; Khanna N; Furrer H; Vetter P; Bernasconi E; Vernazza P; Hoffmann M; Kouyos RD; Nemeth J;
PLoS Biol; 2020 Dec; 18(12):e3000963. PubMed ID: 33284802
[TBL] [Abstract][Full Text] [Related]
20. IL-1RA in the supernatant of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus is useful for discriminating active tuberculosis from latent infection.
Akashi S; Suzukawa M; Takeda K; Asari I; Kawashima M; Ohshima N; Inoue E; Sato R; Shimada M; Suzuki J; Yamane A; Tamura A; Ohta K; Tohma S; Teruya K; Nagai H
J Infect Chemother; 2021 Apr; 27(4):617-624. PubMed ID: 33317988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
